NCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
Henan Cancer Hospital
King Abdullah Medical City
State Scientific Centre of Coloproctology, Russian Federation
Anhui Provincial Hospital
National Cancer Center, Korea